@article {417,
	title = {Malignancies after hematopoietic stem cell transplantation: many questions, some answers},
	journal = {Blood},
	volume = {91},
	year = {1998},
	note = {0006-4971 (Print) Journal Article Review},
	month = {42064},
	pages = {1833 - 44},
	keywords = {*Hematopoietic Stem Cell Transplantation / adverse effects, Antineoplastic Agents / adverse effects, B-Lymphocytes / pathology, Comorbidity, control / therapy, Disease Susceptibility, Graft vs Host Disease / complications, Hematologic Neoplasms / epidemiology / etiology, Herpesviridae Infections / epidemiology, Herpesvirus 4, Human, Humans, Immunologic Deficiency Syndromes / therapy, Immunosuppressive Agents / adverse effects, Incidence, Lymphoproliferative Disorders / epidemiology / etiology / prevention \&, Myelodysplastic Syndromes / epidemiology / etiology, Neoplasms / *epidemiology / etiology / therapy, Neoplasms, Radiation-Induced / epidemiology / etiology, Neoplasms, Second Primary / epidemiology / etiology, Research Support, U.S. Gov{\textquoteright}t, P.H.S., Risk Factors, Time Factors, Transplantation Conditioning / adverse effects, Transplantation, Autologous, Transplantation, Homologous / adverse effects, Tumor Virus Infections / epidemiology, Whole-Body Irradiation / adverse effects},
	author = {Deeg,H. J. and Socie,G.}
}
